Hiroki Sato

1.5k citations
72 papers · 1.1k indexed · h-index 21
Topics
Antibiotics Pharmacokinetics and Efficacy (7 papers)Antibiotic Resistance in Bacteria (6 papers)Pharmacy and Medical Practices (6 papers)

In The Last Decade

Hiroki Sato

67 papers receiving 1.1k citations

Peers

Hiroki Sato
Comparison fields: 5 of 132
  • Organic Chemistry 368
  • Molecular Biology 264
  • Pharmacology 231
  • Epidemiology 84
  • Oncology 81
Replace Kelly Chatman with:
Kelly Chatman United States
Suneela Dhaneshwar India
T.D. Bethke Germany
Benita Wiatrak Poland
Dong‐Jun Fu China
Imre Klebovich Hungary
Jin‐Yi Wan China
Noor B. Almandil Saudi Arabia
Koichi Aizawa Japan
Hiroki Sato relative to Kelly Chatman United States Kelly Chatman's profile →
Citations per field
00.5×4.1×
Kelly Chatman · 1×
Citations per year

Countries citing papers authored by Hiroki Sato

Since Specialization
Citations

This map shows the geographic impact of Hiroki Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Sato more than expected).

Fields of papers citing papers by Hiroki Sato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Sato. The network helps show where Hiroki Sato may publish in the future.

Co-authorship network of co-authors of Hiroki Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Sato. A scholar is included among the top collaborators of Hiroki Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Sato. Hiroki Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 13
3 10
4 8
5 13
6 27
7 1
8 8
9 24
10 1
11 56
12 3
13
What influences workers in deciding to support unions?: evidence from Japan- focus on workers' understanding of their rights-
0
14 2
15 101
16 8
17 6
18 17
19 3
20 2

About Hiroki Sato

Hiroki Sato is a scholar working on Fuel Technology, Molecular Medicine and Pharmacology, having authored 72 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Pharmacy and Medical Practices (6 papers). The work is most often cited by research in Fuel Technology (13 citations), Pharmacology (231 citations) and Organic Chemistry (368 citations). Hiroki Sato has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Jeffrey Vietri, Ko Matsudaira, Toshinaga Tsuji, Seiichi Nakamura, Nobuhide Watanabe, Yoshio Kamiya, Wataru Saburi, Shunichi Hashimoto, Hirokazu Matsui and Miwako Mori. Their work appears in journals such as PLoS ONE, ACS Catalysis and Tetrahedron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026